Drugs marketed under international unpatented name Tropicamide are now listed as medications requiring name-specific and quantitative accounting at healthcare institutions.
The new regulation was issued per Directive of the Ministry of Healthcare of Ukraine No 845 of 29.10.2012 on the amendment of the Rules of Issuing Prescriptions and Orders for Medicinal Products and Medical Devices and of the Procedure of Selling Medicinal Products and Medical Devices at Drugstores and their Subdivisions approved by Directive of the Ministry of Healthcare of Ukraine No 360 of 19.07.2005, the press service of Apteka weekly reports.
Just as a reminder, the above document will come into force as of the official publication date. It is expected to be published in The Official Journal of Ukraine, issue No 87 dated 23.11.2012.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...